ED

Elizabeth Douville

Life sciences executive

Montreal, Quebec

Overview

Work Experience

I

IRICoR

  • President & CEO

    2023

A

AmorChem

  • Founder

    2011

    AmorChem is a leading early-stage venture capital investing in research innovation and creating next-gen biotech companies in life sciences. The fund has 95M$ under management for pre-seed, seed and Series A investments.

GC

Genome Canada

  • Chair

    2019

  • Board Member

    2016 - 2019

CT

Corbin Therapeutics Inc

  • Board Member

    2017

    Corbin Therapeutics develops USP15 inhibitors to treat and manage neuroinflamation.

SI

SemaThera Inc

  • Board Member

    2020

    SemaThera develops anti-SEMA3A biologics to treat diabetic macular edema.

  • Board Observer

    2018 - 2020

IP

Inversago Pharma

  • Board Observer

    2018 - 2022

    Inversago Pharma develops next gen CB1 inverse agonists to treat Prader-Willi Syndrome

B

BioCanRx

  • Board Member

    2015 - 2020

B

BIOQuebec

  • Board Member

    2013 - 2018

Education

Investments

Inversago Pharma

Series A

Total Funding: $110M

Semathera

Series Unknown

Total Funding: $3M

Alethia BioTherapeutics

Series A

Total Funding: $16M

Relevant Websites